Berylliosis: Clinical Trials

2 completed, 1 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	2	Completed 1, Terminated 1
Phase 2	2	Completed 1, Terminated 1

Follow Berylliosis: new trials by email Literature Review of Berylliosis trials Research Report on Berylliosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Targeting Oxidative Stress in Chronic Beryllium Disease Mesalamine, Placebo - Chronic Beryllium Disease	Phase 1 / Phase 2	Completed	National Jewish Health	18	2010-03-01	2018-10-12
Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis Sarcoidosis, Berylliosis		Completed	National Jewish Health	400	2007-03-01	2014-09-26
Beryllium Infliximab Study: Clinical Interventional Trial Infliximab, Placebo - Berylliosis, Beryllium Disease	Phase 1 / Phase 2	Terminated	Maier, Lisa, M.D.	13	2005-02-01	2016-06-02

Narrower conditions

Sarcoidosis (1)

Broader conditions

Lung Diseases (3)  ·  Lung Diseases, Interstitial (3)  ·  Lung Injury (3)  ·  Occupational Diseases (3)  ·  Pneumoconiosis (3)  ·  Respiratory Tract Diseases (3)  ·  Hemic and Lymphatic Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Delayed (1)  ·  Immune System Diseases (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)

Interventions

Infliximab (1)  ·  Mesalamine (1)  ·  Sugars (1)

Sponsors

National Jewish Health (2)  ·  Maier, Lisa, M.D. (1)

Countries

United States (3)

Top investigators

Brian Day, PhD (1)  ·  Lisa A Maier, MD,MSPH (1)  ·  Lisa A. Maier, M.D., MSPH (1)  ·  Lisa A. Maier, MD, MSPH (1)

Results publications

PMID 22974830

NIH funding

1UL1RR025780 (1), R21HL081766 (1)